Insights and commentary from our University experts, thought leaders, and graduate students on pharmaceutical, science, healthcare, and educational topics.

05/17/2016

Dr. Amy Jessop honored with Public Health Recognition Award

Dr. Amy Jessop, an associate professor of health policy and public health at University of the Sciences and director of Hepatitis Treatment Research and Education Center, received the Individual Public Health Recognition Award from the College of Physicians of Philadelphia on May 10 for her work with Prevention Point Philadelphia. Dr. Jessop is a member of the board of directors at Prevention Point Philadelphia (PPP), an organization focused on reducing the risk for those who are at high risk for contracting HIV/AIDS, Hepatitis and other blood-borne diseases. The organization was founded in 1991 as an underground syringe exchange. It was...

Continue reading "Dr. Amy Jessop honored with Public Health Recognition Award" »

05/10/2016

What is Big Data and how will it revolutionize the health industry? Part III

Big Data has already made an impact in many industries, and is transforming how we think of healthcare and public health. It will continue to revolutionize healthcare, pharmaceuticals, clinical trial management, administration, and all aspects of the health industry. The US has the highest healthcare costs in the world, and our outcomes are often mediocre. The application of Big Data techniques will help reduce these costs and improve outcomes. As the field matures, we will see a cumulative effect, as insights build atop each other. Big Data is a revolution, but it is still in its infancy. The truth is,...

Continue reading "What is Big Data and how will it revolutionize the health industry? Part III" »

05/05/2016

The European Biosimilars Market

In previous blogs, I have written about what biosimilars are and have speculated about the development of the US biosimilars industry. While the US biosimilars market may not fully mature for another decade, the European biosimilars market has been expanding for years. In this blog, I will analyze what the European biosimilars market looks like and whether it is a preview of the US biosimilars market. The biosimilars market in Europe has existed now for over a decade. The first approved biosimilar was a somatotropin in 2006. Since then, Europe has seen 22 biosimilars emerge in several different drug classes...

Continue reading "The European Biosimilars Market" »

04/29/2016

What is Big Data and how will it revolutionize the health industry? Part II

Big Data is poised to revolutionize the healthcare industry. The revolution goes beyond just analyzing text based notes. It is being used in predictive analytics, prescriptive analytics, genomics, and in many other ways. You may have heard the term “Internet of Things.” This refers to the fact that many devices are now connected to the Internet, from your phone to your car to wearables like the Apple Watch and FitBit. It is estimated that by 2020, there will be 25 billion connected devices. These devices capture real time data, and allow for real-time alerts. They produce tons of data on...

Continue reading "What is Big Data and how will it revolutionize the health industry? Part II" »

04/28/2016

The Reference Product Strikes Back

A lot of consideration has gone into biosimilars and what they mean for the biologics drug market. The idea behind biosimilars is that they will reduce costs by providing cheaper alternatives to existing biologic drugs. As mentioned in previous blogs however, biosimilars are by no means a cheap and simple cure to high drug costs. There are several road blocks like high production costs and long periods of development biosimilars must face on the way to the market place. These road blocks cut into the discounts biosimilars could offer. This leaves a unique opening for reference products. Reference products could...

Continue reading "The Reference Product Strikes Back" »

04/25/2016

More Faculty, Staff, Student and Alumni Achievements

Student Mathematics Papers Presented at Section Meeting Faculty sponsor and Professor of Mathematics Dr. Salar Alsardary led a group of USciences students to present papers at the Eastern Pennsylvania and Delaware Section of the Mathematical Association of America at Muhlenberg College on April 2, 2016. The undergraduates presented on three topics. The History of Algorithms: Deion Floyd PhC’17, Eli Halpern C’17 Sudoko: Matt Marshall BI’19, Tori Lugiano C’19 The History of Knight's Tour: Brianna Mengini PharmD’20, Brielle Okulicz PharmD’20, Jaden Daubert PharmD’20 Student Life’s Deena Smith, a Residence Director for Goodman and Wilson Halls, was recently accepted into the Regional...

Continue reading "More Faculty, Staff, Student and Alumni Achievements" »

04/21/2016

Biosimilars and P&T Committees

Imagine that you are on an APPE rotation at a local managed care organization (MCOs) and your preceptor asks you to research a medication that is being considered on the Pharmacy and Therapeutics Committee (P&T Committee). Because P&T Committees are inter-professional committees designed to consider whether to add a new medication to a formulary, you as a student pharmacist are expected to find information to help make that decision. Since pharmacists are expected to speak the language of business and science, your research must cover a broad area. As you begin to research the medication, you notice that it is...

Continue reading "Biosimilars and P&T Committees " »

04/18/2016

PCP Student Receives Travel Grant for National Conference

Christina Ly PharmD’17 was one of only four students selected nationwide to receive a travel grant worth up to $2,500 from the American College of Apothecaries (ACA), International Academy of Compounding Pharmacists (IACP) and American College of Veterinary Pharmacists (ACVP) Foundations. Ly received the award at the 2016 ACA/IACP/ACVP Educational Conference held from February 24-27, 2016, in Coronado, CA. The Educational Conference is a joint endeavor by the three hosting organizations, ACA, IACP, and ACVP. The conference provides continuing education sessions to pharmacists and pharmacy technicians that are focused on topics related to independent pharmacy, pharmaceutical compounding, pharmacy law, and...

Continue reading "PCP Student Receives Travel Grant for National Conference" »

04/15/2016

Introduction to Biosimilars

As clinical guidelines are published and the pharmaceutical industry innovates, the practice of pharmacy changes. At the fore front of innovation is the biologic. These medications are capable of achieving clinical outcomes that traditional small chemical medications cannot. Biologics are not without disadvantages. In addition to being more challenging to create, these medications are also orders of magnitude more expensive. This cost has kept biologics as an alternative or not even an option to patients who would greatly benefit from their use. In order to solve this issue, the pharmaceutical industry is developing biosimilars, or medications that are similar to...

Continue reading "Introduction to Biosimilars" »

04/12/2016

What is Big Data and How Will it Revolutionize the Health Industry? - PART I

Big Data is one of those new terms that has been getting a lot of media coverage. If you’re like me, you have been confused by what it even means. The short answer is that Big Data is a new approach for organizing and analyzing the massive amounts of data being generated each day. Big Data allows for insights that were practically impossible under traditional approaches. We are at the doorstep of a revolution, yet we still haven’t maximized our potential with old techniques and approaches. Before we dive into the future of Big Data, it helps to first realize...

Continue reading "What is Big Data and How Will it Revolutionize the Health Industry? - PART I" »

My Photo


USciences Experts Guide
A listing of faculty members and their areas of expertise for the media

© 2011 University of the Sciences in Philadelphia • 600 South 43rd Street • Philadelphia, PA 19104 • 215.596.8800